| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 01/23/2023 | 7.68% | Barclays | $96 → $120 | Maintains | Overweight |
| 11/16/2022 | 21.14% | Credit Suisse | → $135 | Initiates Coverage On | → Outperform |
| 11/03/2022 | 3.19% | Needham | $125 → $115 | Maintains | Buy |
| 11/03/2022 | 7.68% | Raymond James | $240 → $120 | Maintains | Outperform |
| 11/03/2022 | -13.85% | Barclays | $130 → $96 | Maintains | Overweight |
| 09/13/2022 | 16.65% | Barclays | $195 → $130 | Maintains | Overweight |
| 08/04/2022 | 74.98% | Barclays | $230 → $195 | Maintains | Overweight |
| 08/04/2022 | 115.36% | Raymond James | $320 → $240 | Maintains | Outperform |
| 08/04/2022 | 88.44% | Needham | $225 → $210 | Maintains | Buy |
| 07/25/2022 | 106.39% | Barclays | $325 → $230 | Maintains | Overweight |
| 05/05/2022 | 124.34% | Needham | $300 → $250 | Maintains | Buy |
| 02/03/2022 | 169.2% | Needham | $330 → $300 | Maintains | Buy |
| 11/05/2021 | 191.64% | Barclays | $245 → $325 | Maintains | Overweight |
| 11/04/2021 | 191.64% | Credit Suisse | $225 → $325 | Maintains | Outperform |
| 11/04/2021 | 187.15% | Raymond James | $180 → $320 | Maintains | Outperform |
| 11/04/2021 | 196.12% | Needham | $180 → $330 | Maintains | Buy |
| 09/14/2021 | 119.85% | Barclays | $175 → $245 | Maintains | Overweight |
| 09/02/2021 | 133.31% | Roth Capital | $200 → $260 | Maintains | Buy |
| 08/30/2021 | 101.9% | Credit Suisse | → $225 | Initiates Coverage On | → Outperform |
| 08/05/2021 | 79.47% | Roth Capital | $130 → $200 | Maintains | Buy |
| 08/05/2021 | 61.52% | Raymond James | $150 → $180 | Maintains | Outperform |
| 08/05/2021 | 61.52% | Needham | $125 → $180 | Maintains | Buy |
| 05/05/2021 | 16.65% | Roth Capital | $150 → $130 | Maintains | Buy |
| 05/05/2021 | 12.17% | Needham | $150 → $125 | Maintains | Buy |
| 02/04/2021 | 34.6% | Raymond James | $110 → $150 | Maintains | Outperform |
| 02/04/2021 | 34.6% | Roth Capital | $130 → $150 | Maintains | Buy |
| 02/04/2021 | 34.6% | Needham | $105 → $150 | Maintains | Buy |
| 01/26/2021 | 34.6% | Barclays | $100 → $150 | Maintains | Overweight |
| 01/04/2021 | 16.65% | Roth Capital | $110 → $130 | Maintains | Buy |
| 11/05/2020 | -1.29% | Raymond James | $80 → $110 | Maintains | Outperform |
| 11/05/2020 | -5.78% | Needham | $75 → $105 | Maintains | Buy |
| 09/01/2020 | -35.39% | Stifel | $64 → $72 | Maintains | Buy |
| 09/01/2020 | -28.21% | Raymond James | $70 → $80 | Maintains | Outperform |
| 09/01/2020 | -32.7% | Needham | $67 → $75 | Maintains | Buy |
| 08/06/2020 | -42.57% | Stifel | $61 → $64 | Maintains | Buy |
| 08/06/2020 | -37.19% | Raymond James | $42 → $70 | Maintains | Outperform |
| 08/06/2020 | -39.88% | Needham | $55 → $67 | Maintains | Buy |
| 06/30/2020 | — | William Blair | Initiates Coverage On | → Outperform | |
| 06/17/2020 | -55.13% | Barclays | $24 → $50 | Maintains | Overweight |
| 06/16/2020 | -62.31% | Raymond James | $25 → $42 | Maintains | Outperform |
| 06/15/2020 | -64.11% | Needham | $27 → $40 | Maintains | Buy |
| 05/07/2020 | -78.46% | Barclays | $25 → $24 | Maintains | Overweight |
| 04/17/2020 | -77.57% | Barclays | $30 → $25 | Maintains | Overweight |
| 04/16/2020 | -76.67% | Stifel | $28 → $26 | Maintains | Buy |
| 04/15/2020 | -75.77% | Needham | $33 → $27 | Maintains | Buy |
| 04/13/2020 | -77.57% | Raymond James | $30 → $25 | Maintains | Outperform |
| 04/09/2020 | -94.62% | BTIG | $11 → $6 | Maintains | Buy |
| 02/06/2020 | -70.39% | Needham | $30 → $33 | Maintains | Buy |
| 02/06/2020 | -64.11% | Roth Capital | $25 → $40 | Maintains | Buy |
| 01/17/2020 | -73.08% | Needham | $26 → $30 | Maintains | Buy |
| 12/16/2019 | -79.36% | Stifel | → $23 | Initiates Coverage On | → Buy |
| 12/16/2019 | — | Roth Capital | Initiates Coverage On | → Buy | |
| 12/16/2019 | -76.67% | Needham | → $26 | Initiates Coverage On | → Buy |
| 12/16/2019 | -78.46% | Raymond James | → $24 | Initiates Coverage On | → Outperform |
| 12/16/2019 | -79.36% | Stifel | → $23 | Initiates Coverage On | → Buy |
What is the target price for SiTime (SITM)?
The latest price target for SiTime (NASDAQ: SITM) was reported by Barclays on January 23, 2023. The analyst firm set a price target for $120.00 expecting SITM to rise to within 12 months (a possible 7.68% upside). 12 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for SiTime (SITM)?
The latest analyst rating for SiTime (NASDAQ: SITM) was provided by Barclays, and SiTime maintained their overweight rating.
When is the next analyst rating going to be posted or updated for SiTime (SITM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of SiTime, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for SiTime was filed on January 23, 2023 so you should expect the next rating to be made available sometime around January 23, 2024.
Is the Analyst Rating SiTime (SITM) correct?
While ratings are subjective and will change, the latest SiTime (SITM) rating was a maintained with a price target of $96.00 to $120.00. The current price SiTime (SITM) is trading at is $111.44, which is within the analyst's predicted range.